National Cancer Plan Sets Out Ambition To Improve Outcomes

The government has published its National Cancer Plan for England, setting out a ten-year ambition to improve cancer survival, increase early diagnosis, modernise services and reduce longstanding inequalities in outcomes across the country. The Plan follows a series of recent announcements, outlining specific measures that will sit beneath the new framework, including targeted investment in early diagnosis and new support for families facing the cost of accessing specialist care.

Cancer remains one of the country’s biggest causes of premature death, with survival rates in England lagging behind several comparable countries. The Plan positions cancer care as a litmus test for wider NHS reform, with a stated aim to save an additional 320,000 lives by 2035 through earlier diagnosis, faster treatment and improved quality of life for people living with cancer.

What The Plan Sets Out To Do

At its core, the National Cancer Plan commits to:

• Earlier diagnosis, including expanding screening programmes and increasing diagnostic capacity, with the goal of diagnosing three in four cancers at stage 1 or 2 by 2035
• Improved performance against cancer waiting time standards, supported by new diagnostic hubs, digital pathways and productivity improvements
• Greater use of innovation, including genomics, data and digital tools, to personalise care and speed up treatment decisions
• A stronger focus on prevention, recognising that around a third of cancers are preventable
• Better patient experience and quality of life, including support during and after treatment

The Plan also places a strong emphasis on tackling inequalities, acknowledging that people in more deprived and underserved areas are more likely to be diagnosed later and have poorer outcomes.

Recent Announcements Linked To The Plan

Leading up to publication, the government announced a number of measures framed as early delivery of the Plan’s priorities.

One of the most significant announcements for families has been new funding to cover travel costs for children and young people with cancer. From 2026, up to £10 million a year will be available to support families with the cost of travelling to and from treatment, regardless of income. This responds to evidence that more than a third of families travel over an hour to reach specialist children’s cancer centres, often making repeated journeys over many months.

The government has also announced a £200 million, three-year Neighbourhood Early Diagnosis Fund, aimed at reducing gaps in cancer screening uptake and catching more cancers at an earlier stage.

Cancer Alliances and neighbourhood health services will be expected to work with local communities to design targeted approaches, including mobile screening and outreach in areas with persistently low uptake.

Read the National Cancer Plan Policy Document here

Several elements of the Plan and associated announcements have clear relevance for rural areas.

Support with travel costs for children with cancer is likely to be particularly important for rural families, who often face longer journeys to reach specialist centres and higher associated costs. Removing financial barriers to access recognises the reality of distance and travel time for families living further from services.

Similarly, the emphasis on community-based and mobile approaches to screening and diagnosis could help address some access challenges in rural and coastal communities, where transport, workforce capacity and service centralisation can all affect uptake.

The Plan’s focus on prevention, early diagnosis and neighbourhood-level delivery aligns with the principle that services should be designed around people’s lives, rather than assuming easy access to large hospitals or urban centres.

While the Plan sets out a strong national ambition, questions remain about how consistently its commitments will translate into improved access for rural communities.

The Plan does not set out rural-specific delivery mechanisms or funding formulas, and much will depend on how Cancer Alliances, integrated care systems and neighbourhood health services interpret and implement the approach locally. Workforce availability, transport connectivity and digital infrastructure will remain critical enablers, particularly in sparsely populated areas.

There is also limited detail on how success will be measured across different types of places. As RSN’s Delivering for All roadmap highlights, national metrics can mask rural realities unless they explicitly account for distance, dispersion and higher costs of service delivery.

Kerry Booth, Chief Executive, Rural Services Network: The National Cancer Plan marks a clear statement of intent to improve cancer outcomes and reduce inequalities across England. For rural communities, recent commitments on travel costs and neighbourhood-level diagnosis are welcome signals that access barriers are being recognised. As delivery moves forward, continued attention will be needed to ensure that rural needs are fully reflected in funding decisions, performance measures and service design, so that ambition translates into genuinely equitable access to cancer care, regardless of where people live.